• Apr 24, 2025

Apogee (NASDAQ:APOG) Exceeds Q1 Expectations, Full-Year Sales Guidance is Optimistic

Architectural products company Apogee (NASDAQ:APOG) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 4.5% year on year to $345.7 million. The company’s full-year revenue guidance of $1.4 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $0.89 per share was 2.3% above analysts’ consensus estimates.

  • Apr 24, 2025

S&P 500, Nasdaq inch higher on tech boost, earnings weigh on Dow

Wall Street's main indexes were mixed on Thursday, with the S&P 500 and the Nasdaq rising, as investors assessed a slew of mixed corporate results and monitored developments in U.S.-China trade war. The White House on Wednesday indicated that it was open to reducing sweeping tariffs on China, and President Donald Trump stepped back from his attacks on Federal Reserve Chairman Jerome Powell, sending stock indexes higher. But the optimism faded when Treasury Secretary Scott Bessent said a move to reduce levies would not come unilaterally, while China said in response that the U.S. should lift all unilateral tariff measures against China if it "truly" wanted to solve the trade issue.

  • Apr 24, 2025

LKQ (NASDAQ:LKQ) Misses Q1 Sales Targets, Stock Drops

Automotive parts company LKQ (NASDAQ:LKQ) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.5% year on year to $3.46 billion. Its non-GAAP profit of $0.79 per share was 1.5% above analysts’ consensus estimates.

  • Apr 24, 2025

Dow warns of earnings pressure due to tariff uncertainty

(Reuters) -Chemicals firm Dow Inc said on Thursday that it expects extended pressure on earnings as uncertainty from U.S. President Donald Trump's erratic trade policies adds to macroeconomic volatility. Along with other chemicals firms, Dow has been struggling with higher feedstock and energy costs as well as weak demand and prices for its products, especially in markets such as Europe. "Our industry is in one of the most protracted downcycles in decades," CEO Jim Fitterling said in a post-earnings call.

  • Apr 24, 2025

Republican task force chief wants to shield Fed from political influence, including Trump

WASHINGTON (Reuters) -A Republican lawmaker tasked with scrutinizing Federal Reserve monetary policy wants the U.S. Congress to help stabilize financial markets by insulating the central bank from political influence, including from President Donald Trump. After days of market turmoil triggered by Trump's attacks on Fed Chairman Jerome Powell, Representative Frank Lucas said the president ultimately made the right call by stating clearly this week that he has no intention of firing the central bank chief.

  • Apr 24, 2025

West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars

Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $1.45 per share was 18.1% above analysts’ consensus estimates.

  • Apr 24, 2025

Analysts game out use of Fed toolkit if market needs central bank's help

NEW YORK (Reuters) -Market participants unsettled by the Trump administration's choppy policy rollout are working to game out what the Federal Reserve would do if asset prices spiral out of control and require stabilization by the U.S. central bank. The anxiety arises from weeks of volatile trading and big price declines across a range of securities due to President Donald Trump's seesawing tariffs announcements, which are widely expected to stoke inflation while depressing growth and hiring. A more recent wave of price swings followed on the heels of Trump's attacks on the Fed for not cutting interest rates since he returned to power in January and his public musings about firing Fed Chair Jerome Powell.